Covalon Technologies Targets Growth Amidst Revenue Shift
Company Announcements

Covalon Technologies Targets Growth Amidst Revenue Shift

Covalon Technologies (TSE:COV) has released an update.

Covalon Technologies Ltd. reported a 36% growth in U.S. product revenue for the first quarter of fiscal 2024, despite a 25% overall revenue drop to $4.7M due to decreased international sales and a decline in development and consulting services. The company’s gross margin slightly improved to 61%, and with the new CEO’s focus on operational efficiency and growth, Covalon is aiming for EBITDA profitability within the fiscal year.

For further insights into TSE:COV stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskCovalon Showcases Pediatric Vascular Innovations at APHON
TipRanks Canadian Auto-Generated NewsdeskCovalon Technologies Soars with Q3 Financial Growth
TipRanks Canadian Auto-Generated NewsdeskCovalon Technologies to Unveil Q3 Financial Results
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App